Literature DB >> 31729287

Application of Machine Learning Techniques to Predict Binding Affinity for Drug Targets: A Study of Cyclin-Dependent Kinase 2.

Gabriela Bitencourt-Ferreira1, Amauri Duarte da Silva2, Walter Filgueira de Azevedo1.   

Abstract

BACKGROUND: The elucidation of the structure of cyclin-dependent kinase 2 (CDK2) made it possible to develop targeted scoring functions for virtual screening aimed to identify new inhibitors for this enzyme. CDK2 is a protein target for the development of drugs intended to modulate cellcycle progression and control. Such drugs have potential anticancer activities.
OBJECTIVE: Our goal here is to review recent applications of machine learning methods to predict ligand- binding affinity for protein targets. To assess the predictive performance of classical scoring functions and targeted scoring functions, we focused our analysis on CDK2 structures.
METHODS: We have experimental structural data for hundreds of binary complexes of CDK2 with different ligands, many of them with inhibition constant information. We investigate here computational methods to calculate the binding affinity of CDK2 through classical scoring functions and machine- learning models.
RESULTS: Analysis of the predictive performance of classical scoring functions available in docking programs such as Molegro Virtual Docker, AutoDock4, and Autodock Vina indicated that these methods failed to predict binding affinity with significant correlation with experimental data. Targeted scoring functions developed through supervised machine learning techniques showed a significant correlation with experimental data.
CONCLUSION: Here, we described the application of supervised machine learning techniques to generate a scoring function to predict binding affinity. Machine learning models showed superior predictive performance when compared with classical scoring functions. Analysis of the computational models obtained through machine learning could capture essential structural features responsible for binding affinity against CDK2. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  CDK2; Machine learning; cancer; drug design; kinase; mass-spring system

Year:  2021        PMID: 31729287     DOI: 10.2174/2213275912666191102162959

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Sulfonylamide Compounds as CDK2 Inhibitors for Treating Cancer.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-09-13       Impact factor: 4.632

2.  Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD).

Authors:  Jai Woo Lee; Miguel A Maria-Solano; Thi Ngoc Lan Vu; Sanghee Yoon; Sun Choi
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

3.  The First Insight Into the Supramolecular System of D,L-α-Difluoromethylornithine: A New Antiviral Perspective.

Authors:  Joanna Bojarska; Roger New; Paweł Borowiecki; Milan Remko; Martin Breza; Izabela D Madura; Andrzej Fruziński; Anna Pietrzak; Wojciech M Wolf
Journal:  Front Chem       Date:  2021-05-13       Impact factor: 5.221

4.  Novel and versatile artificial intelligence algorithms for investigating possible GHSR1α and DRD1 agonists for Alzheimer's disease.

Authors:  Zi-Qiang Tang; Lu Zhao; Guan-Xing Chen; Calvin Yu-Chian Chen
Journal:  RSC Adv       Date:  2021-02-04       Impact factor: 3.361

5.  Deep Learning in Drug Design: Protein-Ligand Binding Affinity Prediction.

Authors:  Mohammad A Rezaei; Yanjun Li; Dapeng Wu; Xiaolin Li; Chenglong Li
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2022-02-03       Impact factor: 3.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.